Playback speed
10 seconds
Dual EGFR-VEGF Pathway Inhibition for EGFRm NSCLC: RELAY Data on 1L Ramucirumab + Erlotinib, Osimertinib +/- Bevacizumab as 1L & in Pretreated Patients
186 views
April 20, 2021
Login to view comments.
Click here to Login